GleamWall
中文EN

BAX BAXTER INTERNATIONAL INC

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 10456 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.3%
TTM net income YoY-112.0%
TTM EPS YoY-115.2%
Revenue 3-yr CAGR0.7%
Net income 3-yr CAGR—

Margins

Gross margin30.1%
Operating margin-1.9%
Net margin-6.2%
FCF margin—
EBITDA margin3.8%

Returns

ROE-10.5%
ROA-3.6%
ROIC (approx.)-3.5%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets66.6%
Debt / equity0.00x
Current ratio1.79x
Interest coverage-0.75x

Cash quality & payout

Operating cash flow / net income-2.27x
Accruals ratio-11.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$2.98B$2.96B$2.70B$2.97B$2.83B$2.81B$2.62B$2.75B
Cost of revenue$1.98B$1.93B$1.81B$2.40B$1.89B$1.82B$1.76B$1.79B
Gross profit$994.00M$1.03B$891.00M$577.00M$950.00M$991.00M$861.00M$959.00M
R&D expense$125.00M$129.00M$139.00M$126.00M$118.00M$134.00M$140.00M$211.00M
SG&A expense$730.00M$735.00M$728.00M$761.00M$708.00M$718.00M$703.00M$761.00M
Operating income$225.00M$217.00M$66.00M-$729.00M$172.00M$191.00M$58.00M-$435.00M
Interest expense-$13.00M-$13.00M-$12.00M$331.00M-$10.00M-$14.00M-$17.00M$465.00M
Pretax income$417.00M$158.00M-$6.00M-$756.00M$121.00M$133.00M-$3.00M-$521.00M
Income tax$119.00M$23.00M$11.00M$279.00M$172.00M$11.00M-$67.00M-$33.00M
Net income$294.00M$126.00M-$15.00M-$1.13B-$46.00M$91.00M$126.00M-$512.00M
EBITDA$319.00M$311.00M$303.00M-$489.00M$262.00M$297.00M$305.00M-$190.00M
EPS (basic)0.570.24-0.03—-0.090.180.25-1.00
EPS (diluted)0.570.24-0.03—-0.090.180.25-1.00
Dividends declared per share0.010.010.010.010.170.170.170.17
Weighted avg. shares (diluted)520.00M518.00M515.00M—514.00M514.00M514.00M—
Balance sheet
Cash & equivalents$1.98B$2.15B$2.02B$1.97B$1.73B$1.69B$2.29B$1.76B
Receivables$1.78B$1.86B$1.70B$1.86B$1.78B$1.77B$1.65B$1.68B
Inventory$2.30B$2.26B$2.32B$2.23B$2.46B$2.38B$2.17B$2.05B
Current assets$6.83B$6.99B$6.85B$6.87B$6.93B$6.75B$7.04B$8.85B
PP&E, net$2.87B$2.91B$2.91B$2.91B$2.81B$2.80B$2.72B$2.87B
Goodwill$4.87B$4.89B$4.90B$4.93B$5.40B$5.39B$5.34B$5.28B
Intangibles$3.93B$4.07B$4.22B$4.37B$4.80B$4.95B$5.08B$5.22B
Total assets$19.41B$19.79B$19.85B$20.05B$21.07B$21.05B$21.30B$25.78B
Current liabilities$3.81B$3.59B$3.69B$2.97B$3.77B$2.94B$3.48B$6.51B
Short-term debt$0$0$0$1.00M$4.00M$6.00M$11.00M$2.13B
Long-term debt———$9.47B———$10.37B
Total debt———$9.47B———$12.50B
Total liabilities$12.94B$13.61B$13.83B$13.95B$13.85B$13.75B$14.25B$18.76B
Shareholders' equity$6.50B$6.21B$6.04B$6.13B$7.24B$7.32B$7.08B$6.96B
Net debt———$7.51B———$10.74B
Cash flow statement
Operating cash flow$558.00M$285.00M$213.00M$584.00M$237.00M$217.00M-$193.00M$488.00M
Investing cash flow-$110.00M-$117.00M-$133.00M-$198.00M-$111.00M-$115.00M$3.27B-$205.00M
Financing cash flow-$620.00M-$31.00M-$11.00M-$147.00M-$81.00M-$762.00M-$3.23B$141.00M
Depreciation & amortization$94.00M$94.00M$237.00M$240.00M$90.00M$106.00M$247.00M$245.00M
Stock-based compensation$30.00M$33.00M$10.00M$37.00M$35.00M$35.00M$10.00M$39.00M
Dividends paid$5.00M$5.00M$5.00M$87.00M$87.00M$87.00M$87.00M$147.00M

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.